New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
08:19 EDTBIOLBIOLASE CEO resigns, Jeffrey Nugent named chairman, interim CEO
BIOLASE announced with the decisive confirmation from the Delaware Supreme Court on June 12, of the Delaware Chancery Court's May 21 ruling, the board has been established as Paul Clark, Dr. Fred Moll, Dr. Norman Nemoy, Federico Pignatelli, and Jim Talevich. The board today added Jeffrey Nugent as the sixth member of the board. Following the Delaware Supreme Court's ruling, on June 12, Pignatelli resigned from his roles as chairman and CEO. Also the board elected Clark as chairman of the board. Clark served as chairman, CEO, and president of ICOS. Nugent has accepted the role of interim CEO while a formal search is initiated to appoint a permanent CEO.
News For BIOL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 18, 2015
16:51 EDTBIOLBIOLASE CEO Jeffrey Nugent to step down, Harold Flynn appointed CEO
BIOLASE (BIOL) announced that Harold Flynn Jr. will become president and CEO, effective July 13. The current president and CEO Jeffrey Nugent will step down at that time. Since 2007, Flynn has been president of Zimmer Dental, a manufacturer and provider of medical devices for the dental market. Zimmer Dental is a division of Zimmer Holdings (ZMH).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use